NeuroMetrix PE Ratio 2010-2023 | NURO
Current and historical p/e ratio for NeuroMetrix (NURO) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. NeuroMetrix PE ratio as of April 23, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| NeuroMetrix PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-04-24 | 4.33 | 0.00 | |
| 2023-12-31 | 3.60 | $-6.23 | 0.00 |
| 2023-09-30 | 5.73 | $-5.52 | 0.00 |
| 2023-06-30 | 7.80 | $-5.68 | 0.00 |
| 2023-03-31 | 11.76 | $-5.28 | 0.00 |
| 2022-12-31 | 11.92 | $-4.88 | 0.00 |
| 2022-09-30 | 22.32 | $-5.12 | 0.00 |
| 2022-03-31 | 33.28 | $-4.32 | 0.00 |
| 2021-12-31 | 40.16 | $-3.36 | 0.00 |
| 2021-09-30 | 81.12 | $-2.56 | 0.00 |
| 2021-06-30 | 27.28 | $-2.96 | 0.00 |
| 2021-03-31 | 27.28 | $-2.48 | 0.00 |
| 2020-12-31 | 25.28 | $-4.56 | 0.00 |
| 2022-06-30 | 29.44 | $-7.76 | 0.00 |
| 2020-09-30 | 13.60 | $-6.40 | 0.00 |
| 2020-06-30 | 16.40 | $-17.04 | 0.00 |
| 2020-03-31 | 9.09 | $-44.40 | 0.00 |
| 2019-12-31 | 34.40 | $-28.80 | 0.00 |
| 2019-09-30 | 25.60 | $-44.80 | 0.00 |
| 2019-06-30 | 32.80 | $-21.60 | 0.00 |
| 2019-03-31 | 88.00 | $11.20 | 7.86 |
| 2018-12-31 | 60.80 | $5.60 | 10.86 |
| 2018-09-30 | 106.40 | $21.60 | 4.93 |
| 2018-06-30 | 104.80 | $-239.20 | 0.00 |
| 2018-03-31 | 112.80 | $-441.60 | 0.00 |
| 2017-12-31 | 138.32 | $-1,030.40 | 0.00 |
| 2017-09-30 | 163.20 | $-1,363.20 | 0.00 |
| 2017-06-30 | 215.20 | $-1,600.80 | 0.00 |
| 2017-03-31 | 396.80 | $-4,838.40 | 0.00 |
| 2016-12-31 | 472.70 | $-4,896.00 | 0.00 |
| 2016-09-30 | 998.40 | $-6,604.80 | 0.00 |
| 2016-06-30 | 1062.40 | $-6,784.00 | 0.00 |
| 2016-03-31 | 1171.20 | $-4,576.00 | 0.00 |
| 2015-12-31 | 1267.20 | $-4,576.00 | 0.00 |
| 2015-09-30 | 2259.20 | $-3,456.00 | 0.00 |
| 2015-06-30 | 2328.06 | $-3,276.80 | 0.00 |
| 2015-03-31 | 4300.80 | $-4,224.00 | 0.00 |
| 2014-12-31 | 4992.00 | $-4,121.60 | 0.00 |
| 2014-09-30 | 4608.00 | $-5,427.20 | 0.00 |
| 2014-06-30 | 4966.40 | $-5,606.40 | 0.00 |
| 2014-03-31 | 5990.40 | $-5,785.60 | 0.00 |
| 2013-12-31 | 7475.20 | $-7,961.60 | 0.00 |
| 2013-09-30 | 4224.00 | $-8,012.80 | 0.00 |
| 2013-06-30 | 5120.00 | $-10,572.16 | 0.00 |
| 2013-03-31 | 6323.20 | $-11,595.48 | 0.00 |
| 2012-12-31 | 6643.20 | $-13,949.67 | 0.00 |
| 2012-09-30 | 9369.60 | $-21,346.13 | 0.00 |
| 2012-06-30 | 9523.20 | $-27,796.04 | 0.00 |
| 2012-03-31 | 11366.40 | $-34,551.06 | 0.00 |
| 2011-12-31 | 19200.00 | $-40,538.05 | 0.00 |
| 2011-09-30 | 26880.00 | $-47,445.35 | 0.00 |
| 2011-06-30 | 37334.02 | $-51,588.96 | 0.00 |
| 2011-03-31 | 47923.20 | $-59,880.05 | 0.00 |
| 2010-12-31 | 62659.58 | $-67,249.90 | 0.00 |
| 2010-09-30 | 55249.92 | $-48,825.27 | 0.00 |
| 2010-06-30 | 105117.70 | $-87,516.99 | 0.00 |
| 2010-03-31 | 176025.60 | $-81,068.37 | 0.00 |
| 2009-12-31 | 227635.20 | $-70,934.82 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.009B | $0.006B |
| Neurometrix is a medical device company establishing a new standard of care through the design, development and sale of proprietary products used to diagnose neuropathies. Neuropathies are diseases of the peripheral nerves and parts of the spine that frequently are caused by or associated with diabetes, low back pain and carpal tunnel syndrome, as well as other clinical disorders. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $186.688B | 24.51 |
| Stryker (SYK) | United States | $127.423B | 31.59 |
| Medtronic (MDT) | Ireland | $107.939B | 15.28 |
| Boston Scientific (BSX) | United States | $101.215B | 33.65 |
| EssilorLuxottica (ESLOY) | France | $99.656B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.872B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.401B | 30.04 |
| ResMed (RMD) | United States | $27.097B | 27.09 |
| Terumo (TRUMY) | Japan | $25.416B | 35.90 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.968B | 16.07 |
| Baxter (BAX) | United States | $20.831B | 15.19 |
| Koninklijke Philips (PHG) | Netherlands | $19.511B | 15.56 |
| Insulet (PODD) | United States | $11.713B | 61.50 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.842B | 0.00 |
| Demant (WILYY) | Denmark | $9.943B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.136B | 24.24 |
| BellRing Brands (BRBR) | United States | $7.357B | 39.56 |
| Lantheus Holdings (LNTH) | United States | $4.415B | 11.40 |
| Haemonetics (HAE) | United States | $4.320B | 22.10 |
| Perrigo (PRGO) | Ireland | $4.132B | 11.82 |
| GN Store Nord (GNNDY) | Denmark | $3.937B | 25.50 |
| Prestige Consumer Healthcare (PBH) | United States | $3.536B | 16.72 |
| Envista Holdings (NVST) | United States | $3.475B | 13.22 |
| QuidelOrtho (QDEL) | United States | $2.702B | 9.81 |
| Neogen (NEOG) | United States | $2.666B | 25.65 |
| Green Thumb Industries (GTBIF) | United States | $2.566B | 81.33 |
| ICU Medical (ICUI) | United States | $2.382B | 17.77 |
| TG Therapeutics (TGTX) | United States | $2.202B | 712.50 |
| Owens & Minor (OMI) | United States | $1.959B | 18.80 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.941B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.788B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.662B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.475B | 45.95 |
| InMode (INMD) | Israel | $1.459B | 7.55 |
| LeMaitre Vascular (LMAT) | United States | $1.442B | 47.58 |
| Warby Parker (WRBY) | United States | $1.318B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.304B | 9.81 |
| AtriCure (ATRC) | United States | $1.121B | 0.00 |
| MacroGenics (MGNX) | United States | $1.015B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.905B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.771B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.701B | 15.15 |
| Cresco Labs (CRLBF) | United States | $0.695B | 0.00 |
| Evolus (EOLS) | United States | $0.678B | 0.00 |
| Quanterix (QTRX) | United States | $0.616B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.551B | 11.94 |
| Jin Medical (ZJYL) | China | $0.543B | 0.00 |
| Valneva SE (VALN) | France | $0.539B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.492B | 0.00 |
| PetIQ (PETQ) | United States | $0.489B | 18.24 |
| ZimVie (ZIMV) | United States | $0.437B | 26.75 |
| OraSure Technologies (OSUR) | United States | $0.423B | 7.00 |
| Biote (BTMD) | United States | $0.415B | 3.95 |
| Aurora Cannabis (ACB) | Canada | $0.405B | 0.00 |
| Surmodics (SRDX) | United States | $0.383B | 41.42 |
| Zynex (ZYXI) | United States | $0.362B | 41.70 |
| Viemed Healthcare (VMD) | United States | $0.312B | 31.00 |
| Cerus (CERS) | United States | $0.305B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.281B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.273B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.242B | 14.78 |
| Organigram Holdings (OGI) | Canada | $0.201B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.191B | 0.00 |
| Veru (VERU) | United States | $0.187B | 0.00 |
| Omeros (OMER) | United States | $0.179B | 0.00 |
| High Tide (HITI) | Canada | $0.170B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.164B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.152B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.133B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.132B | 66.41 |
| FitLife Brands (FTLF) | United States | $0.129B | 20.70 |
| InterCure (INCR) | Israel | $0.118B | 20.00 |
| Fonar (FONR) | United States | $0.101B | 8.70 |
| Cellectar Biosciences (CLRB) | United States | $0.100B | 0.00 |
| MariMed (MRMD) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.086B | 0.00 |
| Chimerix (CMRX) | United States | $0.083B | 0.00 |
| Brainsway (BWAY) | Israel | $0.082B | 0.00 |
| Safety Shot (SHOT) | United States | $0.080B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.062B | 4.04 |
| Zevia PBC (ZVIA) | United States | $0.061B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.048B | 0.00 |
| Apyx Medical (APYX) | United States | $0.046B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.045B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| Bright Green (BGXX) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.54 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.020B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.019B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.011B | 75.27 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.001B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |